The Effects of Antrodia Cinnamomea Fruiting Body Extract on Quality of Life and Chemotherapy Side Effects in Patients With Lung Cancer Undergoing Platinum-Based Chemotherapy
Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This randomized trial will test whether Antrodia cinnamomea supplement improves quality of life in lung cancer patients receiving platinum-based chemotherapy. Participants at Tri-Service General Hospital will be randomized to receive either Antrodia cinnamomea capsules or placebo for 3 months, with follow-up to 6 months (24 weeks). Primary outcomes include nausea/vomiting scores, sleep quality, quality of life, and cancer symptoms.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 99
Healthy Volunteers: f
View:
• Pathologically and radio-graphically diagnosed lung cancer
• Age greater than 18 years
• Received platinum-based chemotherapy
• Life expectancy of six months or longer
Locations
Other Locations
Taiwan
Tri-Service General Hospital
RECRUITING
Taipei
Contact Information
Primary
Chen-Liang Tsai
doc10376@gmail.com
886-2-8792-3311
Time Frame
Start Date: 2025-11-24
Estimated Completion Date: 2027-09-30
Participants
Target number of participants: 40
Treatments
Experimental: Antrodia cinnamomea plus turmeric and probiotics
Participants will receive capsules containing Antrodia cinnamomea extract, turmeric, and probiotics taken orally once daily for 3 months during platinum-based chemotherapy treatment.
Active_comparator: Turmeric and probiotics only
Participants will receive capsules containing turmeric and probiotics (without Antrodia cinnamomea) taken orally once daily for 3 months during platinum-based chemotherapy treatment.
Related Therapeutic Areas
Sponsors
Leads: Tri-Service General Hospital
Collaborators: Balay Biotechnology Corporation